trial · primary record
JNJ-101556143
Prostatic Neoplasms
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 100 |
| Primary completion | 2030-05-20 |
| Primary endpoint | Overall Response Rate (ORR) |
| Registry ID | NCT07832292 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:55:52.765Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07832292
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Jnj-101556143 · compound